PF

Professor Farah

Optiscan Imaging Limited | Chief Executive Officer, Managing Director
Dr Farah is an executive, academic, researcher and author with 25 years of experience in the healthcare, biotech and medical research sectors. He is dual trained oral clinician and maxillofacial pathologist with appointments at Hollywood Private Hospital, Precision Pathology and Genomics for Life. Professor Farah is a leading Australian expert in oral cancer and precancerous pathology based on his clinical and research having published 250 clinical and scientific articles and a textbook. He is a former Dean and Chief Executive of the Oral Health Centre at the University of Western Australia. He serves as a non-executive director and Honorary Treasurer of the Australian and New Zealand Head and Neck Cancer Society.

Company and Roles

Company
Title
Tenure
Since
OIL
Optiscan Imaging Limited
  • Chief Executive Officer
  • Managing Director
4yrsMay 2021

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
OIL
Optiscan Imaging Limited
21/03/25N/A8,899,9859,000,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
OIL
Optiscan Imaging Limited
21/03/25
Buy
12,984$0.120$1,555On-market trade
OIL
Optiscan Imaging Limited
17/03/25
Buy
195,385$0.120$23,474On-market trade
OIL
Optiscan Imaging Limited
13/07/23
Issued
2,166,667$0.080$173,333Rights issue
OIL
Optiscan Imaging Limited
08/12/22
Issued
6,000,000$0.060$360,000Issue of securities
OIL
Optiscan Imaging Limited
09/03/22
Issued
12,000,000$0.145$1,740,000Issue of options